[	0	1	O
Activation	1	11	O
of	12	14	O
sterol	15	21	B-Gene_or_gene_product
regulatory	22	32	I-Gene_or_gene_product
element	33	40	I-Gene_or_gene_product
binding	41	48	I-Gene_or_gene_product
protein	49	56	I-Gene_or_gene_product
and	57	60	O
its	61	64	O
involvement	65	76	O
in	77	79	O
endothelial	80	91	B-Cell
cell	92	96	I-Cell
migration	97	106	O
]	106	107	O

OBJECTIVE	109	118	O
:	118	119	O
To	120	122	O
study	123	128	O
the	129	132	O
activation	133	143	O
of	144	146	O
sterol	147	153	B-Gene_or_gene_product
regulatory	154	164	I-Gene_or_gene_product
element	165	172	I-Gene_or_gene_product
binding	173	180	I-Gene_or_gene_product
protein	181	188	I-Gene_or_gene_product
(	189	190	O
SREBP	190	195	B-Gene_or_gene_product
)	195	196	O
and	197	200	O
its	201	204	O
critical	205	213	O
role	214	218	O
in	219	221	O
endothelial	222	233	B-Cell
cell	234	238	I-Cell
migration	239	248	O
.	248	249	O

METHODS	250	257	O
:	257	258	O
Bovine	259	265	B-Organism
aortic	266	272	B-Cell
endothelial	273	284	I-Cell
cells	285	290	I-Cell
(	291	292	O
ECs	292	295	B-Cell
)	295	296	O
were	297	301	O
cultured	302	310	O
.	310	311	O

The	312	315	O
expression	316	326	O
of	327	329	O
SREBP	330	335	B-Gene_or_gene_product
and	336	339	O
Cdc42	340	345	B-Gene_or_gene_product
were	346	350	O
determined	351	361	O
by	362	364	O
Western	365	372	O
blot	373	377	O
and	378	381	O
quantitative	382	394	O
real	395	399	O
-	399	400	O
time	400	404	O
PCR	405	408	O
.	408	409	O

Moreover	410	418	O
,	418	419	O
outward	420	427	O
growth	428	434	O
migration	435	444	O
model	445	450	O
and	451	454	O
transwell	455	464	O
chamber	465	472	O
assay	473	478	O
were	479	483	O
used	484	488	O
to	489	491	O
detect	492	498	O
ECs	499	502	B-Cell
migration	503	512	O
.	512	513	O

RESULTS	514	521	O
:	521	522	O
(	523	524	O
1	524	525	O
)	525	526	O
SREBP	527	532	B-Gene_or_gene_product
was	533	536	O
activated	537	546	O
during	547	553	O
ECs	554	557	B-Cell
migration	558	567	O
.	567	568	O

Western	569	576	O
blot	577	581	O
analysis	582	590	O
demonstrated	591	603	O
increased	604	613	O
active	614	620	O
form	621	625	O
SREBP	626	631	B-Gene_or_gene_product
in	632	634	O
migrating	635	644	O
as	645	647	O
compared	648	656	O
to	657	659	O
non	660	663	O
-	663	664	O
migrating	664	673	O
ECs	674	677	B-Cell
population	678	688	O
.	688	689	O

SREBP	690	695	B-Gene_or_gene_product
activation	696	706	O
decreased	707	716	O
as	717	719	O
ECs	720	723	B-Cell
migration	724	733	O
slowed	734	740	O
;	740	741	O
(	741	742	O
2	742	743	O
)	743	744	O
Coincidental	745	757	O
with	758	762	O
SREBP	763	768	B-Gene_or_gene_product
activation	769	779	O
,	779	780	O
mRNA	781	785	O
expression	786	796	O
of	797	799	O
its	800	803	O
target	804	810	O
genes	811	816	O
such	817	821	O
as	822	824	O
low	825	828	B-Gene_or_gene_product
density	829	836	I-Gene_or_gene_product
lipoprotein	837	848	I-Gene_or_gene_product
receptor	849	857	I-Gene_or_gene_product
,	857	858	O
HMG	859	862	B-Gene_or_gene_product
-	862	863	I-Gene_or_gene_product
CoA	863	866	I-Gene_or_gene_product
reductase	867	876	I-Gene_or_gene_product
,	876	877	O
and	878	881	O
fatty	882	887	B-Gene_or_gene_product
acid	888	892	I-Gene_or_gene_product
synthase	893	901	I-Gene_or_gene_product
also	902	906	O
increased	907	916	O
in	917	919	O
migrating	920	929	O
ECs	930	933	B-Cell
population	934	944	O
as	945	947	O
detected	948	956	O
by	957	959	O
real	960	964	O
-	964	965	O
time	965	969	O
PCR	970	973	O
;	973	974	O
(	975	976	O
3	976	977	O
)	977	978	O
Migration	979	988	O
induced	989	996	O
SREBP	997	1002	B-Gene_or_gene_product
activation	1003	1013	O
in	1014	1016	O
ECs	1017	1020	B-Cell
was	1021	1024	O
inhibited	1025	1034	O
by	1035	1037	O
SREBP	1038	1043	B-Gene_or_gene_product
-	1043	1044	I-Gene_or_gene_product
acting	1044	1050	I-Gene_or_gene_product
protein	1051	1058	I-Gene_or_gene_product
RNAi	1059	1063	O
and	1064	1067	O
pharmacologically	1068	1085	O
by	1086	1088	O
25	1089	1091	B-Drug_or_compound
-	1091	1092	I-Drug_or_compound
hydroxycholesterol	1092	1110	I-Drug_or_compound
;	1110	1111	O
(	1112	1113	O
4	1113	1114	O
)	1114	1115	O
Inhibition	1116	1126	O
of	1127	1129	O
SREBP	1130	1135	B-Gene_or_gene_product
led	1136	1139	O
to	1140	1142	O
decreased	1143	1152	O
ECs	1153	1156	B-Cell
migration	1157	1166	O
in	1167	1169	O
various	1170	1177	O
models	1178	1184	O
;	1184	1185	O
(	1186	1187	O
5	1187	1188	O
)	1188	1189	O
Cells	1190	1195	B-Cell
genetically	1196	1207	O
deficient	1208	1217	O
in	1218	1220	O
SREBP	1221	1226	B-Gene_or_gene_product
-	1226	1227	I-Gene_or_gene_product
acting	1227	1233	I-Gene_or_gene_product
protein	1234	1241	I-Gene_or_gene_product
,	1241	1242	O
S1P	1243	1246	B-Gene_or_gene_product
,	1246	1247	O
or	1248	1250	O
S2P	1251	1254	B-Gene_or_gene_product
,	1254	1255	O
phenotypically	1256	1270	O
exhibited	1271	1280	O
impaired	1281	1289	O
migration	1290	1299	O
;	1299	1300	O
(	1301	1302	O
6	1302	1303	O
)	1303	1304	O
SREBP	1305	1310	B-Gene_or_gene_product
inhibition	1311	1321	O
in	1322	1324	O
ECs	1325	1328	B-Cell
suppressed	1329	1339	O
the	1340	1343	O
activity	1344	1352	O
of	1353	1355	O
small	1356	1361	O
GTPase	1362	1368	O
Cdc42	1369	1374	B-Gene_or_gene_product
,	1374	1375	O
a	1376	1377	O
key	1378	1381	O
molecule	1382	1390	O
for	1391	1394	O
ECs	1395	1398	B-Cell
motility	1399	1407	O
.	1407	1408	O

CONCLUSIONS	1409	1420	O
:	1420	1421	O
SREBP	1422	1427	B-Gene_or_gene_product
is	1428	1430	O
activated	1431	1440	O
during	1441	1447	O
and	1448	1451	O
plays	1452	1457	O
a	1458	1459	O
critical	1460	1468	O
role	1469	1473	O
in	1474	1476	O
ECs	1477	1480	B-Cell
migration	1481	1490	O
.	1490	1491	O

Targeting	1492	1501	O
SREBP	1502	1507	B-Gene_or_gene_product
could	1508	1513	O
become	1514	1520	O
a	1521	1522	O
novel	1523	1528	O
approach	1529	1537	O
in	1538	1540	O
fighting	1541	1549	O
diseases	1550	1558	O
involving	1559	1568	O
abnormal	1569	1577	O
ECs	1578	1581	B-Cell
migration	1582	1591	O
.	1591	1592	O

